| Huang, Jian |
NCT05131841: Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC |
|
|
| Recruiting | 4 | 60 | RoW | Cipterbin Combined With Vinorelbine | Zhejiang Cancer Hospital, Proswell Medical Corporation | Metastatic Breast Cancer | 12/22 | 12/22 | | |
CLOVER, NCT03926091: Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer |
|
|
| Recruiting | 3 | 2172 | RoW | Docetaxel, docetaxel injection, Cyclophosphamide, Cyclophosphamide injection | Fudan University | Breast Cancer | 11/24 | 11/25 | | |
NCT05600322: Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer |
|
|
| Completed | 3 | 158 | RoW | Hexaminolevulinate Hydrochloride, Hexvix, Richard Wolf Photodynamic Diagnostic Equipment (PDD) system, System Blue | Photocure, Jiangsu Yahong Meditech Co., Ltd aka Asieris, Richard Wolf GmbH, Tigermed-Jyton Co., Ltd. | Bladder Cancer | 07/23 | 07/23 | | |
NCT06241755: Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC) |
|
|
| Recruiting | 3 | 412 | RoW | BCG for Therapeutic Use, BCG | Chengdu CoenBiotech Co., Ltd, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Non-Muscle Invasive Bladder Cancer | 09/25 | 09/26 | | |
NCT05433480: A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer |
|
|
| Active, not recruiting | 3 | 274 | RoW | BPI-16350, placebo, Fulvestrant | Betta Pharmaceuticals Co., Ltd. | Breast Cancer | 12/23 | 07/25 | | |
| Active, not recruiting | 3 | 654 | Europe, Canada, Japan, US, RoW | Tucatinib, TUKYSA, ONT-380, ARRY-380, Trastuzumab, Herceptin, Herceptin Hylecta, Pertuzumab, Perjeta, Combination product: Trastuzumab + Pertuzumab, Phesgo, Placebo | Seagen Inc., Merck Sharp & Dohme LLC | HER2 Positive Breast Cancer | 05/25 | 10/27 | | |
JSKN003-302, NCT06079983: JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects |
|
|
| Not yet recruiting | 3 | 400 | RoW | JSKN003, Capecitabine tablets, Gemcitabine hydrochloride for injection, Vinorelbine tartrate injection, Paclitaxel for injection (albumin-bound type), Docetaxel injection, Eribulin mesylate injection | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Breast Cancer | 04/25 | 03/29 | | |
| Recruiting | 3 | 314 | RoW | Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502), Control drug: Trastuzumab emtansine (Kadcyla, T-DM1) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Breast Cancer | 07/25 | 01/26 | | |
| Active, not recruiting | 3 | 650 | Europe, Canada, Japan, US, RoW | Pirtobrutinib, LOXO-305, LY3527727, Ibrutinib | Loxo Oncology, Inc., Eli Lilly and Company | Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma | 02/25 | 08/28 | | |
NCT05075512: The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer |
|
|
| Recruiting | 2 | 40 | RoW | anlotinib, fulvestrant, AL3818 | Zhejiang Cancer Hospital | Breast Neoplasm Female | 08/23 | 08/26 | | |
NCT04799847: Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine |
|
|
| Recruiting | 1/2 | 161 | RoW | Catumaxomab | LintonPharm Co.,Ltd. | Bladder Cancer | 11/24 | 11/24 | | |
| Recruiting | 1/2 | 300 | RoW | JSKN003 | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Advanced Solid Tumor | 12/24 | 12/25 | | |
NCT06001580: A Phase I Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors |
|
|
| Recruiting | 1 | 36 | RoW | BR101 | Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.Ltd | Advanced Solid Tumor | 12/23 | 06/26 | | |
NCT06672263: A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia |
|
|
| Not yet recruiting | 1 | 120 | RoW | TQB3911 tablets | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Chronic Myelogenous Leukemia | 09/26 | 12/26 | | |
NCT05106868: Acupuncture for Patients With Major Depressive Disorder |
|
|
| Not yet recruiting | N/A | 123 | NA | acupuncture | Chengdu University of Traditional Chinese Medicine | Major Depressive Disorder | 12/22 | 06/23 | | |
VR-TSP, NCT06574451: Effectiveness and Safety of Adjuvant Software Based on Virtual Reality for Post-thoracoscopic Surgery Pain |
|
|
| Recruiting | N/A | 215 | RoW | VR-assisted postoperative analgesia | Guangdong Provincial People's Hospital, Guang Dong Liang Zi Health Consulting Co., Ltd, Guang Dong, China., Tianjin Medical University General Hospital, Ruijin Hospital, Maoming People's Hospital | Acute Postoperative Pain, Video-assisted Thoracic Surgery, Virtual Reality | 04/25 | 04/25 | | |
NCT04948528: Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for Upper Tract Urothelial Carcinoma Detection |
|
|
| Recruiting | N/A | 490 | RoW | Active Comparator: Surgery Pathology or Cystoscopy, Active Comparator: Clinical Diagnosis | AnchorDx Medical Co., Ltd., Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Peking University First Hospital, Peking University Third Hospital, Peking Union Medical College Hospital, The Affiliated Hospital of Qingdao University, First Affiliated Hospital, Sun Yat-Sen University, Sir Run Run Shaw Hospital, The First Affiliated Hospital of Zhengzhou University | Upper Tract Urothelial Carcinoma | 06/23 | 12/23 | | |
NCT04744506: Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy |
|
|
| Not yet recruiting | N/A | 126 | RoW | Tissue Marker Clip, Carbon Nanoparticle Suspension Injection | Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Natural Science Foundation of China | Breast Cancer, Surgery, Lymph Node Metastases | 07/28 | 07/29 | | |
NCT04966949: Lateral Prostate Capsule Sparing Versus Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male |
|
|
| Not yet recruiting | N/A | 100 | RoW | lateral prostate capsule sparing or neurovascular bundles sparing | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, The Seventh Affiliated Hospital, Sun Yat-sen University | Bladder Cancer | 08/23 | 08/23 | | |
ONAC, NCT06155305: Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer |
|
|
| Recruiting | N/A | 58 | RoW | Biopsy | Second Affiliated Hospital, School of Medicine, Zhejiang University | Organoids, Breast Cancer, Neoadjuvant Chemotherapy | 12/24 | 06/25 | | |
NCT06658080: Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer |
|
|
| Recruiting | N/A | 90 | RoW | organoid drug test | Second Affiliated Hospital, School of Medicine, Zhejiang University | Breast Cancer Metastatic, Hydrothorax, Ascites, Organoids, Drug Evaluation | 10/26 | 10/27 | | |
NCT04966975: Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant Chemotherapy |
|
|
| Not yet recruiting | N/A | 60 | NA | neoadjuvant chemotherapy | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, Shantou Central Hospital | Bladder Cancer | 08/22 | 08/22 | | |
NCT04966130: Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder. |
|
|
| Not yet recruiting | N/A | 96 | NA | | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University | Muscle-Invasive Bladder Carcinoma | 08/22 | 08/22 | | |
NCT04966962: Establishment and Validation of an Early Diagnostic Model for Bladder Cancer Based on Serum and Urine Metabolomics |
|
|
| Not yet recruiting | N/A | 180 | NA | serum and urine metabolomics | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, The Seventh Affiliated Hospital, Sun Yat-sen University | Bladder Cancer | 08/22 | 08/22 | | |
NCT04958343: Application and Clinical Effectiveness of Pelvic Reconstruction in Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder in the Male |
|
|
| Not yet recruiting | N/A | 100 | RoW | pelvic reconstruction | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, The Seventh Affiliated Hospital, Sun Yat-sen University | Bladder Cancer | 07/23 | 07/23 | | |
NCT04958330: Lateral Prostate Capsule Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male |
|
|
| Not yet recruiting | N/A | 100 | RoW | lateral prostate capsule sparing | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, The Seventh Affiliated Hospital, Sun Yat-sen University | Bladder Cancer | 07/23 | 07/23 | | |
NCT05018429: Nerve Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male |
|
|
| Not yet recruiting | N/A | 100 | RoW | nerve sparing | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, Shantou Central Hospital | Bladder Cancer | 09/23 | 09/23 | | |
| Qian, Huan |
NCT04937101: The Safety and Effectiveness of Local Injection of Antihistamines in Treatment of Inflammatory Skin Diseases |
|
|
| Recruiting | N/A | 78 | RoW | Chlorpheniramine-Codeine | Second Affiliated Hospital, School of Medicine, Zhejiang University | Inflammatory Skin Disease | 12/21 | 12/21 | | |
| Committee, Human Subject Research Ethics Committee Human Subject Research Ethics |
NCT04937101: The Safety and Effectiveness of Local Injection of Antihistamines in Treatment of Inflammatory Skin Diseases |
|
|
| Recruiting | N/A | 78 | RoW | Chlorpheniramine-Codeine | Second Affiliated Hospital, School of Medicine, Zhejiang University | Inflammatory Skin Disease | 12/21 | 12/21 | | |
NCT05857475: Efficacy of CPAP Therapy on Pulmonary Function Test in Patients With COPD-OSA Overlap Syndrome |
|
|
| Completed | N/A | 10 | RoW | CPAP therapy, Control | Mahidol University | COPD, OSA, Lung Function Decreased | 12/23 | 01/24 | | |
| chen, zhigang |
NCT05058040: A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) |
|
|
| Active, not recruiting | 4 | 2500 | RoW | Sodium Oligomannate Capsules | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer Disease | 01/25 | 04/25 | | |
NCT05269173: Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease |
|
|
| Completed | 2 | 240 | RoW | Flos gossypii flavonoids tablet | Capital Medical University, Xinjiang Uygur Pharmaceutical Co., Ltd. | Alzheimer Disease | 08/24 | 11/24 | | |
ONAC, NCT06155305: Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer |
|
|
| Recruiting | N/A | 58 | RoW | Biopsy | Second Affiliated Hospital, School of Medicine, Zhejiang University | Organoids, Breast Cancer, Neoadjuvant Chemotherapy | 12/24 | 06/25 | | |
NCT06658080: Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer |
|
|
| Recruiting | N/A | 90 | RoW | organoid drug test | Second Affiliated Hospital, School of Medicine, Zhejiang University | Breast Cancer Metastatic, Hydrothorax, Ascites, Organoids, Drug Evaluation | 10/26 | 10/27 | | |
| Jiang, Shou-Yin |
| Recruiting | N/A | 132 | RoW | Ultrasound-guided axillary vein catheterization | Second Affiliated Hospital, School of Medicine, Zhejiang University | Multiple Trauma/Injuries | 07/23 | 12/23 | | |
